NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Research
Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Awards EBSCO Information Services for Delivering Innovative Solutions to Access Medical Research Information for Healthcare Providers - Clinical Decisions product suite from EBSCO earns recognition for modern evidence-based resources that support clinical decision-making, enhance patient satisfaction, and improve outcomes - EBSCO.com
Frost & Sullivan Awards EBSCO Information Services for Delivering Innovative Solutions to Access Medical Research Information for Healthcare Providers

 

NewswireTODAY - /newswire/ - San Antonio, TX, United States, 2022/06/08 - Clinical Decisions product suite from EBSCO earns recognition for modern evidence-based resources that support clinical decision-making, enhance patient satisfaction, and improve outcomes - EBSCO.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Based on its recent analysis of the clinical decision support systems (CDSS) industry, Frost & Sullivan recognizes EBSCO Information Services (EBSCO) and specifically its Clinical Decisions products with the 2022 North America Product Leadership Award for delivering forward-thinking products that support evidence-based clinical decision-making and patient engagement. EBSCO is the world’s trusted source of information for global institutions, with more than 70 years of addressing the research interests of several academic organizations, libraries, medical institutions, and more. DynaMed® and Dynamic Health™ represent the core resources in EBSCO’s Clinical Decisions offerings and are meant to support physicians, advance practice providers, nurses, and allied health professionals.

EBSCO’s Clinical Decisions suite of products is designed to provide healthcare professionals with the most current, evidence-based answers to clinical questions as they arise at the point of care.

“EBSCO is a leading provider of CDSS, shared decision making, and medical research solutions, helping improve patient care by arming healthcare professionals with clinical evidence at the point of care,” said Pavel Zhebrouski, Best Practices Research analyst at Frost & Sullivan. “EBSCO demonstrates high-growth potential. The company is well-positioned in the market, with industry-leading products that provide tremendous value in high-demand sectors.”

The company also invests extensive resources in research, quality, and innovation. A major EBSCO innovation is DynaMed, the company’s flagship CDSS tool, which has seamless integration into the clinical workflow. The solution incorporates smart tools that connect clinicians and patients to optimize clinical decision-making, increase productivity and provide superior personalized care. Clinicians can access the EBSCO tool on-the-go, 24 hours a day, with the DynaMed mobile app to boost efficiency and guarantee actionable information.

DynaMed Decisions™, a unique component of DynaMed, offers evidence-based tools that allow providers to deliver effective patient-centered and personalized care while involving the patient in the care process. These tools are developed by clinical experts who monitor the latest evidence and update content as needed.

“EBSCO is reshaping the CDSS space with its industry-leading, innovative mindset, and customer-centric approach. One example is EBSCO’s DynaMed, as it provides the most current, accurate, and actionable answers to questions vital to improving health outcomes. DynaMed’s evidence-based methodology and literature surveillance are combined with clinical expertise to complement and clarify the information that guides the healthcare team,” noted Victor Camlek, Principal Analyst at Frost & Sullivan. “At the same time, the company incorporates customer feedback into its product roadmap to maximize short-term growth opportunities while providing a path to future revenues. Its powerful customer success management team works closely with customers driving the integration of the capabilities of its innovative solutions throughout the system and helping them succeed in achieving improved outcomes.”

EBSCO Information Services Executive Vice President of Clinical Decisions Betsy Jones says that Frost & Sullivan’s recognition reflects the company’s dedication to making an impact on the healthcare industry. “Healthcare professionals are faced with many challenges, including keeping pace with incoming clinical evidence while providing exceptional patient care. The Frost & Sullivan’s Best Practices Award demonstrates and validates our commitment to improving the lives of clinicians while helping to enhance the clinician-patient interaction with Clinical Decisions, and importantly DynaMed Decisions, for greater clinical and shared decision making. ”

Each year, Frost & Sullivan presents this award to the company that develops a product with innovative features and functionality to gain rapid market acceptance. The award recognizes the quality of the solution and the customer value enhancements it enables.

Frost & Sullivan Best Practices Awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

About EBSCO Information Services

EBSCO Information Services (ebsco.com) is the preeminent provider of online research content and search technologies serving academic, school and public libraries; healthcare and medical institutions; corporations; and government agencies around the world. EBSCO’s Clinical Decisions suite of products is designed to improve patient care by providing healthcare professionals with the most current, evidence-based answers to clinical questions as they arise at the point of care. EBSCO Information Services is a division of EBSCO Industries, Inc., a family owned company since 1944.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Awards EBSCO Information Services for Delivering Innovative Solutions to Access Medical Research Information for Healthcare Providers

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
EBSCO | Frost & Sullivan
Contact: Lindsey Whitaker - Frost.com 
210-477-8457 lindsey.whitaker[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Research Most Recent Related Newswires:

Motorola Solutions Announces New Global R&D Centre in Ireland
Naval Group Announces A New Collaboration Between Public and Private Research Studying the Electromagnetism of Ships
BASF Researching CO2-neutral Production of Bio-based Fumarate Using Bacteria Found in Cow Stomachs
SCHOTT Receives Over €1.3 Million to Advance Nuclear Fusion Research
NASA’s Jet Propulsion Laboratory Enhances Public Safety with CentralSquare Technologies’ Pro Suite
BASF to Research on Alternatives to Animal Testing on Behalf of the European Chemicals Agency (ECHA)
NEC Joins Columbia University-led National Science Foundation Engineering Research Center for Smart Streetscapes (CS3)
Tractebel to Conduct Feasibility Study for Iconic Einstein Telescope
Parexel Recognized with Frost & Sullivan’s 2023 North American Customer Value Leadership Award for Impactful Real-world Evidence Solutions
ABB and Imperial College Extend Carbon Capture Collaboration to Support Future Workforce and Energy Transition
ANDRITZ Opens The Food Innovation Xperience Test Center
Emulate Earns Frost & Sullivan’s 2023 Technology Innovation Leadership Award
CEA and Siemens Collaborate on Research to Expand Applications of Digital Twin for Industry
Innovative Research for Malaria Control Driven by Three Collaborating Parties - Swiss TPH, BASF and Promega
Aichi Cancer Center and NEC Develop an Efficient Method for Identifying Lung Cancer Antigens and Antigen-Specific T Cells

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  BizJobs.com





 
  ©2005-2024 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)